Robert P. Friedland, MD - Publications

Affiliations: 
Neurology University of Louisville, Louisville, KY, United States 
Area:
Alzheimer disease
Website:
http://louisville.edu/medschool/neurology/faculty/Robert_P_Friedland_MD_Chair/contact-Robert_Friedland_MD

165 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bhagat R, Narayanan S, Elnazeir M, Pham TD, Friedland RP, Remmel K, Liu W. Gasperini Syndrome: A Case Report and Systematic Review and Proposing a New Definition. Case Reports in Neurology. 12: 433-439. PMID 33362523 DOI: 10.1159/000510845  0.731
2020 Khaleefah MM, Narayanan S, Dallal HAA, Jones CM, Friedland RP, Palade AE, Remmel KS, Shah JJ. Isolated oculomotor nerve palsy as a manifestation of diffuse large B cell lymphoma: A case report. Oncology Letters. 20: 285. PMID 33014163 DOI: 10.3892/ol.2020.12147  0.702
2020 Qin L, Zhu X, Friedland RP. ApoE and mitochondrial dysfunction. Neurology. PMID 32457209 DOI: 10.1212/Wnl.0000000000009569  0.389
2020 Friedland RP, McMillan JD, Kurlawala Z. What Are the Molecular Mechanisms by Which Functional Bacterial Amyloids Influence Amyloid Beta Deposition and Neuroinflammation in Neurodegenerative Disorders? International Journal of Molecular Sciences. 21. PMID 32121263 DOI: 10.3390/Ijms21051652  0.377
2018 Kurlawala Z, Roberts JA, McMillan JD, Friedland RP. Diazepam Toxicity Presenting as a Dementia Disorder. Journal of Alzheimer's Disease : Jad. PMID 30400100 DOI: 10.3233/Jad-180745  0.376
2017 Raha-Chowdhury R, Henderson JW, Raha AA, Stott SRW, Vuono R, Foscarin S, Wilson L, Annus T, Fincham R, Allinson K, Devalia V, Friedland RP, Holland A, Zaman SH. Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome. Journal of Alzheimer's Disease : Jad. PMID 29278889 DOI: 10.3233/Jad-170814  0.446
2017 Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. Plos Pathogens. 13: e1006654. PMID 29267402 DOI: 10.1371/Journal.Ppat.1006654  0.382
2017 García-Peña C, Álvarez-Cisneros T, Quiroz-Baez R, Friedland RP. Microbiota and Aging. A Review and Commentary. Archives of Medical Research. PMID 29229199 DOI: 10.1016/J.Arcmed.2017.11.005  0.301
2017 Jun GR, Chung J, Mez J, Barber R, Beecham GW, Bennett DA, Buxbaum JD, Byrd GS, Carrasquillo MM, Crane PK, Cruchaga C, De Jager P, Ertekin-Taner N, Evans D, Fallin MD, ... ... Friedland RP, et al. Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28183528 DOI: 10.1016/J.Jalz.2016.12.012  0.4
2016 Raha AA, Henderson JW, Stott SR, Vuono R, Foscarin S, Friedland RP, Zaman SH, Raha-Chowdhury R. Neuroprotective Effect of TREM-2 in Aging and Alzheimer's Disease Model. Journal of Alzheimer's Disease : Jad. PMID 27662313 DOI: 10.3233/Jad-160663  0.399
2016 Roberts AM, Jagadapillai R, Vaishnav RA, Friedland RP, Drinovac R, Lin X, Gozal E. Increased pulmonary arteriolar tone associated with lung oxidative stress and nitric oxide in a mouse model of Alzheimer's disease. Physiological Reports. 4. PMID 27604401 DOI: 10.14814/Phy2.12953  0.345
2015 Banik A, Brown RE, Bamburg J, Lahiri DK, Khurana D, Friedland RP, Chen W, Ding Y, Mudher A, Padjen AL, Mukaetova-Ladinska E, Ihara M, Srivastava S, Padma Srivastava MV, Masters CL, et al. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?1. Journal of Alzheimer's Disease : Jad. 47: 815-43. PMID 26401762 DOI: 10.3233/Jad-150136  0.4
2015 Werner P, Friedland RP, Inzelberg R. Alzheimer's Disease and the Elderly in Israel: Are We Paying Enough Attention to the Topic in the Arab Population? American Journal of Alzheimer's Disease and Other Dementias. PMID 25794510 DOI: 10.1177/1533317515577130  0.349
2015 Planque SA, Nishiyama Y, Sonoda S, Lin Y, Taguchi H, Hara M, Kolodziej S, Mitsuda Y, Gonzalez V, Sait HB, Fukuchi K, Massey RJ, Friedland RP, O'Nuallain B, Sigurdsson EM, et al. Specific amyloid β clearance by a catalytic antibody construct. The Journal of Biological Chemistry. 290: 10229-41. PMID 25724648 DOI: 10.1074/Jbc.M115.641738  0.372
2015 Inzelberg R, Massarwa M, Schechtman E, Strugatsky R, Farrer LA, Friedland RP. Estimating the risk for conversion from mild cognitive impairment to Alzheimer's disease in an elderly Arab community. Journal of Alzheimer's Disease : Jad. 45: 865-71. PMID 25624416 DOI: 10.3233/Jad-142871  0.386
2015 Friedland RP. Mechanisms of molecular mimicry involving the microbiota in neurodegeneration. Journal of Alzheimer's Disease : Jad. 45: 349-62. PMID 25589730 DOI: 10.3233/Jad-142841  0.355
2014 Furman CD, Earnshaw LA, Doukas DJ, Farrer LA, Friedland RP. A case of inappropriate apolipoprotein e testing in Alzheimer's disease due to lack of an informed consent discussion. American Journal of Alzheimer's Disease and Other Dementias. 29: 590-5. PMID 24615498 DOI: 10.1177/1533317514525829  0.366
2013 Raha AA, Vaishnav RA, Friedland RP, Bomford A, Raha-Chowdhury R. The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease. Acta Neuropathologica Communications. 1: 55. PMID 24252754 DOI: 10.1186/2051-5960-1-55  0.376
2013 Fujioka H, Phelix CF, Friedland RP, Zhu X, Perry EA, Castellani RJ, Perry G. Apolipoprotein E4 prevents growth of malaria at the intraerythrocyte stage: implications for differences in racial susceptibility to Alzheimer's disease. Journal of Health Care For the Poor and Underserved. 24: 70-8. PMID 24241262 DOI: 10.1353/Hpu.2014.0009  0.548
2013 Inzelberg R, Afgin AE, Massarwa M, Schechtman E, Israeli-Korn SD, Strugatsky R, Abuful A, Kravitz E, Farrer LA, Friedland RP. Prayer at midlife is associated with reduced risk of cognitive decline in Arabic women. Current Alzheimer Research. 10: 340-6. PMID 23116476 DOI: 10.2174/1567205011310030014  0.35
2013 Inzelberg R, Massarwa M, Schechtman E, Strugatsky R, Israeli-Korn S, Socher A, Afgin AE, Farrer L, Friedland RP. P3-162: Estimating the risk of mild cognitive impairment and conversion to Alzheimer's disease Alzheimer's & Dementia. 9: P612-P612. DOI: 10.1016/J.Jalz.2013.05.1234  0.349
2012 Rothenberg KG, Pi?d?o R, Nagaraj UD, Friedland RP. The complex picture test in dementia. Dementia and Geriatric Cognitive Disorders Extra. 2: 411-7. PMID 23139686 DOI: 10.1159/000342349  0.354
2012 Friedland RP, Shah JJ, Farrer LA, Vardarajan B, Rebolledo-Mendez JD, Mok K, Hardy J. Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat. Frontiers in Neurology. 3: 136. PMID 23060854 DOI: 10.3389/Fneur.2012.00136  0.325
2012 Sabbagh MN, Messis C, Friedland RP, Geula C. The 5th International Conference on Alzheimer's Disease and related disorders in the Middle East, 15-17 May 2009, Limassol Cyprus. Journal of Alzheimer's Disease : Jad. 30: 711-27. PMID 22614876 DOI: 10.3233/Jad-2012-120116  0.407
2012 Afgin AE, Massarwa M, Schechtman E, Israeli-Korn SD, Strugatsky R, Abuful A, Farrer LA, Friedland RP, Inzelberg R. High prevalence of mild cognitive impairment and Alzheimer's disease in arabic villages in northern Israel: impact of gender and education. Journal of Alzheimer's Disease : Jad. 29: 431-9. PMID 22233764 DOI: 10.3233/Jad-2011-111667  0.382
2012 Afgin A, Massarwa M, Schechtman E, Israeli-Korn S, Strugatsky R, Abuful A, Farrer L, Friedland R, Inzelberg R. Conversion from Mild Cognitive Impairment to Alzheimer's Disease in an Elderly Arab Population (P01.088) Neurology. 78: P01.088-P01.088. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.088  0.38
2011 Sherva R, Baldwin CT, Inzelberg R, Vardarajan B, Cupples LA, Lunetta K, Bowirrat A, Naj A, Pericak-Vance M, Friedland RP, Farrer LA. Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data. Journal of Alzheimer's Disease : Jad. 23: 349-59. PMID 21098978 DOI: 10.3233/Jad-2010-100714  0.369
2011 Cuenco KT, Friedland R, Baldwin CT, Guo J, Vardarajan B, Lunetta KL, Cupples LA, Green RC, DeCarli C, Farrer LA. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiology of Aging. 32: 249-56. PMID 19328595 DOI: 10.1016/J.Neurobiolaging.2009.02.014  0.376
2010 Khachaturian AS, Chapman J, Farrer L, Friedland RP, Ebstein R, Grossman I, Hendler T, Hermann B, Inzelberg R, Johnson S, Khachaturian ZS, Lichter-Shapira I, Makeeva O, Mayrl R, Mizrahi E, et al. Healthy aging and preclinical dementia: the United States-Israel Longitudinal Database project. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 475-81. PMID 21044777 DOI: 10.1016/J.Jalz.2010.10.001  0.334
2010 Israeli-Korn SD, Massarwa M, Schechtman E, Strugatsky R, Avni S, Farrer LA, Friedland RP, Inzelberg R. Mild cognitive impairment is associated with mild parkinsonian signs in a door-to-door study. Journal of Alzheimer's Disease : Jad. 22: 1005-13. PMID 20930290 DOI: 10.3233/Jad-2010-101230  0.381
2010 Jun G, Naj AC, Beecham GW, Wang LS, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R, Inzelberg R, Kramer P, Rogaeva E, St George-Hyslop P, et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology. 67: 1473-84. PMID 20697030 DOI: 10.1001/Archneurol.2010.201  0.353
2010 Geula C, Efthymiopoulos S, Friedland RP. The 4th International Symposium on Alzheimer's Disease and Related Disorders in the Middle East, October 26-28, 2007, Athens, Greece. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 17: 86-90. PMID 20462368 DOI: 10.3109/13506129.2010.483120  0.348
2010 Israeli-Korn SD, Masarwa M, Schechtman E, Abuful A, Strugatsky R, Avni S, Farrer LA, Friedland RP, Inzelberg R. Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology. 34: 99-105. PMID 20016220 DOI: 10.1159/000264828  0.358
2010 Hunter S, Friedland RP, Brayne C. Time for a change in the research paradigm for Alzheimer's disease: the value of a chaotic matrix modeling approach. Cns Neuroscience & Therapeutics. 16: 254-62. PMID 20002628 DOI: 10.1111/J.1755-5949.2009.00117.X  0.437
2010 Chen CH, Mizuno T, Elston R, Kariuki MM, Hall K, Unverzagt F, Hendrie H, Gatere S, Kioy P, Patel NB, Friedland RP, Kalaria RN. A comparative study to screen dementia and APOE genotypes in an ageing East African population. Neurobiology of Aging. 31: 732-40. PMID 18703255 DOI: 10.1016/J.Neurobiolaging.2008.06.014  0.393
2010 Goldgaber D, Davies P, Gambetti P, Walker LC, Friedland RP, White LR, Piccardo P, Asher DM. P1-263: Transmission of Alzheimer amyloidosis to chimpanzees and monkeys: Revisited Alzheimer's & Dementia. 6: S250-S250. DOI: 10.1016/J.Jalz.2010.05.815  0.346
2010 Nishiyama Y, Sigurdsson EM, Taguchi H, Hara M, Planque S, Rajamohamedsait HB, Friedland RP, Paul S. Candidate therapeutic antibody with specific ability to catalyze beta-amyloid degradation Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.435  0.319
2010 Gustaw-Rothenberg KA, Friedland RP, Dmoszynska M, Siedlak SL, Smith MA. Transthyretin and Aβ in Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.1719  0.54
2009 Friedland RP, Brayne C. What does the pediatrician need to know about Alzheimer disease? Journal of Developmental and Behavioral Pediatrics : Jdbp. 30: 239-41. PMID 19525717 DOI: 10.1097/Dbp.0B013E3181A7Ee83  0.386
2009 Friedland RP, Petersen RB, Rubenstein R. Bovine spongiform encephalopathy and aquaculture. Journal of Alzheimer's Disease : Jad. 17: 277-9. PMID 19363268 DOI: 10.3233/Jad-2009-1060  0.312
2009 Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, Wharton SB, Weller RO, Brayne C. Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. Bmc Neurology. 9: 3. PMID 19144113 DOI: 10.1186/1471-2377-9-3  0.372
2009 Gustaw-Rothenberg K, Siedlak SL, Lee H, Castellani RJ, Zhu X, Perry G, Petersen RB, Friedland RP, Lerner AJ, Smith MA. P3-073: Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study Alzheimer's & Dementia. 5: P363-P363. DOI: 10.1016/J.Jalz.2009.04.1149  0.637
2008 Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, Hall K, Luchsinger JA, Ogunniyi A, Perry EK, Potocnik F, Prince M, Stewart R, Wimo A, Zhang ZX, Antuono P, et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. The Lancet. Neurology. 7: 812-26. PMID 18667359 DOI: 10.1016/S1474-4422(08)70169-8  0.378
2008 Friedland RP, Tedesco JM, Wilson AC, Atwood CS, Smith MA, Perry G, Zagorski MG. Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. The Journal of Biological Chemistry. 283: 22550-6. PMID 18505725 DOI: 10.1074/Jbc.M802088200  0.613
2008 Taguchi H, Planque S, Nishiyama Y, Szabo P, Weksler ME, Friedland RP, Paul S. Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease. Autoimmunity Reviews. 7: 391-7. PMID 18486927 DOI: 10.1016/J.Autrev.2008.03.004  0.418
2008 Gustaw KA, Garrett MR, Lee HG, Castellani RJ, Zagorski MG, Prakasam A, Siedlak SL, Zhu X, Perry G, Petersen RB, Friedland RP, Smith MA. Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis. Journal of Neurochemistry. 106: 1350-6. PMID 18485104 DOI: 10.1111/J.1471-4159.2008.05477.X  0.635
2008 Taguchi H, Planque S, Nishiyama Y, Symersky J, Boivin S, Szabo P, Friedland RP, Ramsland PA, Edmundson AB, Weksler ME, Paul S. Autoantibody-catalyzed hydrolysis of amyloid beta peptide. The Journal of Biological Chemistry. 283: 4714-22. PMID 18086674 DOI: 10.1074/Jbc.M707983200  0.401
2008 Smith MA, Garrett MR, Lee H, Siedlak SL, Zhu X, Perry G, Friedland RP, Gustaw K. P1-351: A novel approach to diagnosis: Antigen-antibody disassociation in Alzheimer's disease Alzheimer's & Dementia. 4: T321-T321. DOI: 10.1016/J.Jalz.2008.05.933  0.61
2008 Gustaw-Rothenberg KA, Bylina J, Friedland RP, Petot GJ. P4-076: Dietary patterns during early adult life associated with Alzheimer's disease: A population based-study (BERCAL) Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2141  0.339
2008 Taguchi H, Planque S, Nishiyama Y, Szabo P, Weksler ME, Friedland RP, Paul S. P2-363: Increased catalytic autoantibodies to amyloid-β peptide in Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1441  0.364
2007 Petot GJ, Vega U, Traore F, Fritsch T, Debanne SM, Friedland RP, Lerner AJ. Height and Alzheimer's disease: findings from a case-control study. Journal of Alzheimer's Disease : Jad. 11: 337-41. PMID 17851184 DOI: 10.3233/Jad-2007-11310  0.39
2007 Goodenowe DB, Cook LL, Liu J, Lu Y, Jayasinghe DA, Ahiahonu PW, Heath D, Yamazaki Y, Flax J, Krenitsky KF, Sparks DL, Lerner A, Friedland RP, Kudo T, Kamino K, et al. Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia. Journal of Lipid Research. 48: 2485-98. PMID 17664527 DOI: 10.1194/Jlr.P700023-Jlr200  0.393
2007 Friedland RP, Emre M, Geula C. The 3rd International Symposium on Alzheimer's Disease and Related Disorders in the Middle East, Istanbul, Turkey, October 1 - 2, 2005. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 14: 161-8. PMID 17577692 DOI: 10.1080/13506120701259606  0.37
2007 Friedland RP, Armon C. Tales of Pacific tangles: Cycad exposure and Guamanian neurodegenerative diseases. Neurology. 68: 1759-61. PMID 17515536 DOI: 10.1212/01.Wnl.0000266867.20409.1C  0.405
2007 Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, ... ... Friedland RP, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nature Genetics. 39: 168-77. PMID 17220890 DOI: 10.1038/Ng1943  0.414
2007 Bonda DJ, Webber KM, Siedlak SL, Perry G, Friedland RP, Smith MA. The Pathology of Alzheimer Disease Elicits an In Vivo Immunological Response American Journal of Immunology. 3: 10-14. DOI: 10.3844/Ajisp.2007.10.14  0.638
2007 Kishikawa Y, Friedland RP, Ueda H, Kitabayashi Y, Fukui K. Socio-psychological factors in suicide with Alzheimer's disease: Comparative case studies of two patients in the USA and Japan Psychogeriatrics. 7: 37-39. DOI: 10.1111/J.1479-8301.2006.00174.X  0.37
2007 Aliev G, Perry G, Shenk J, Puchowicz M, Xu K, Siedlak S, Obrenovich M, Smith M, Friedland R, Chen S, Ames B, Liu J, DeLaTore J, LaManna J, Koistinaho J. PO13-357 THE PRIMARY PATHOGENETIC ROLE OF VASCULAR HYPOPERFUSION, AND OXIDATIVE STRESS IN ALZHEIMER DISEASE Atherosclerosis Supplements. 8: 105. DOI: 10.1016/S1567-5688(07)71367-3  0.6
2006 Meng Y, Baldwin CT, Bowirrat A, Waraska K, Inzelberg R, Friedland RP, Farrer LA. Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community. American Journal of Human Genetics. 78: 871-7. PMID 16642441 DOI: 10.1086/503687  0.304
2006 Cuenco KT, Zhang J, Go RCP, Friedland RP, Duara R, Kurz A, Sadovnick AD, Akomolafe A, Chui H, Petrovitch H, Tsolaki M, Obisesan TO, Sabbagh MN, Farlow M, Relkin NR, et al. P1-283: Ethnic differences in MRI scans among Alzheimer’s disease patients and unaffected siblings in the MIRAGE Study Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.660  0.306
2006 Lerner AJ, Friedland R, McClendon M, Auchus A. P1-173: Comparison of demographics and referral source of African American (AA) cases and controls in a longitudinal study of Alzheimer's disease Alzheimer's & Dementia. 2: S146-S146. DOI: 10.1016/J.Jalz.2006.05.549  0.364
2006 Lunetta KL, Erlich PM, Go RC, Friedland RP, Duara R, Kurz A, Dessa Sadovnick A, Akomolafe A, Chui H, Petrovitch H, Tsolaki M, Obisesan TO, Sabbagh MN, Farlow M, Relkin NR, et al. P3-165: MRI traits are heritable among Alzheimer disease cases and their siblings in the MIRAGE Study Alzheimer's & Dementia. 2: S422-S423. DOI: 10.1016/J.Jalz.2006.05.1433  0.377
2005 Fritsch T, Smyth KA, Debanne SM, Petot GJ, Friedland RP. Participation in novelty-seeking leisure activities and Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 18: 134-41. PMID 16100102 DOI: 10.1177/0891988705277537  0.357
2005 Lindstrom HA, Fritsch T, Petot G, Smyth KA, Chen CH, Debanne SM, Lerner AJ, Friedland RP. The relationships between television viewing in midlife and the development of Alzheimer's disease in a case-control study. Brain and Cognition. 58: 157-65. PMID 15919546 DOI: 10.1016/J.Bandc.2004.09.020  0.39
2004 Geula C, Emre M, Friedland RP. The 2nd International Symposium on Alzheimer's disease and related disorders in the Middle East, May 1-3, 2003, Istanbul, Turkey. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 11: 276-80. PMID 15678765 DOI: 10.1080/13506120400016232  0.367
2004 Mizrahi EH, Bowirrat A, Jacobsen DW, Korczyn AD, Traore F, Petot GJ, Lerner AJ, Debanne SM, Adunsky A, Dibello PM, Friedland RP. Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel. Journal of the Neurological Sciences. 227: 109-13. PMID 15546600 DOI: 10.1016/J.Jns.2004.08.011  0.341
2004 Petot GJ, Friedland RP. Lipids, diet and Alzheimer disease: an extended summary. Journal of the Neurological Sciences. 226: 31-3. PMID 15537515 DOI: 10.1016/J.Jns.2004.09.007  0.399
2004 Smyth KA, Fritsch T, Cook TB, McClendon MJ, Santillan CE, Friedland RP. Worker functions and traits associated with occupations and the development of AD. Neurology. 63: 498-503. PMID 15304581 DOI: 10.1212/01.Wnl.0000133007.87028.09  0.341
2004 Lee JH, Friedland R, Whitehouse PJ, Woo JI. Twenty-four-hour rhythms of sleep-wake cycle and temperature in Alzheimer's disease. The Journal of Neuropsychiatry and Clinical Neurosciences. 16: 192-8. PMID 15260371 DOI: 10.1176/Appi.Neuropsych.16.2.192  0.36
2004 Castellani RJ, Smith MA, Perry G, Friedland RP. Cerebral amyloid angiopathy: major contributor or decorative response to Alzheimer's disease pathogenesis. Neurobiology of Aging. 25: 599-602; discussion . PMID 15172735 DOI: 10.1016/J.Neurobiolaging.2003.12.019  0.665
2004 Lindstrom HA, Fritsch T, Petot GJ, Smyth KA, Chen CH, Debanne SM, Lerner AJ, Friedland RP. P3-154 The relationships between television viewing in midlife and the development of Alzheimer disease in a case-control study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81306-X  0.378
2004 Petot GJ, Fritsch T, Debanne SM, Traore F, Friedland RP. P2-255 Obesity during the mid-adult years is a risk factor for Alzheimer's disease independent of APOE E4 genotype Neurobiology of Aging. 25: S305. DOI: 10.1016/S0197-4580(04)81001-7  0.33
2004 Friedland RP, Shi J, Smith MA, Perry G, Sparks DL. P2-003 Cholesterol feeding enhances cerebral amyloid beta pathology in beagles Neurobiology of Aging. 25: S224. DOI: 10.1016/S0197-4580(04)80751-6  0.688
2004 Farrer L, Friedland R, Bowirrat A, Green R, Yip A, Inzelberg R, Baldwin C. S2-01-02 Using a genetic approach to understand the vascular basis of Alzheimer disease Neurobiology of Aging. 25: S25. DOI: 10.1016/S0197-4580(04)80080-0  0.359
2003 Aliev G, Seyidova D, Lamb BT, Obrenovich ME, Siedlak SL, Vinters HV, Friedland RP, LaManna JC, Smith MA, Perry G. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Neurological Research. 25: 665-74. PMID 14503022 DOI: 10.1179/016164103101201977  0.654
2003 Farrer LA, Friedland RP, Bowirrat A, Waraska K, Korczyn A, Baldwin CT. Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel. Journal of Molecular Neuroscience : Mn. 20: 207-12. PMID 14500999 DOI: 10.1385/Jmn:20:3:207  0.4
2003 Friedland RP. Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? Archives of Neurology. 60: 923-4. PMID 12873846 DOI: 10.1001/Archneur.60.7.923  0.336
2003 Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, Griffith PA, Friedland RP, Bachman D, Farrer L. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Archives of Neurology. 60: 753-9. PMID 12756140 DOI: 10.1001/Archneur.60.5.753  0.319
2002 Friedland RP. Lipid metabolism, epidemiology, and the mechanisms of Alzheimer's disease. Annals of the New York Academy of Sciences. 977: 387-90. PMID 12480777 DOI: 10.1111/J.1749-6632.2002.Tb04842.X  0.404
2002 Aliev G, Seyidova D, Neal ML, Shi J, Lamb BT, Siedlak SL, Vinters HV, Head E, Perry G, Lamanna JC, Friedland RP, Cotman CW. Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Annals of the New York Academy of Sciences. 977: 45-64. PMID 12480733 DOI: 10.1111/J.1749-6632.2002.Tb04798.X  0.683
2002 Bowirrat A, Friedland RP, Korczyn AD. Vascular dementia among elderly Arabs in Wadi Ara. Journal of the Neurological Sciences. 203: 73-6. PMID 12417360 DOI: 10.1016/S0022-510X(02)00269-1  0.348
2002 Bowirrat A, Friedland RP, Farrer L, Baldwin C, Korczyn A. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. Journal of Molecular Neuroscience : Mn. 19: 239-45. PMID 12212789 DOI: 10.1007/S12031-002-0040-4  0.35
2002 Shi J, Perry G, Berridge MS, Aliev G, Siedlak SL, Smith MA, LaManna JC, Friedland RP. Labeling of cerebral amyloid beta deposits in vivo using intranasal basic fibroblast growth factor and serum amyloid P component in mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 1044-51. PMID 12163630  0.68
2002 Vega U, Kishikawa Y, Ricanati E, Friedland RP. Suicide and Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 10: 484-5. PMID 12095909 DOI: 10.1097/00019442-200207000-00021  0.35
2002 Petot GJ, Debanne SM, Riedel TM, Smyth KA, Koss E, Lerner AJ, Friedland RP. Use of surrogate respondents in a case control study of dietary risk factors for Alzheimer's disease. Journal of the American Dietetic Association. 102: 848-50. PMID 12067055 DOI: 10.1016/S0002-8223(02)90190-2  0.364
2002 Smith MA, Drew KL, Nunomura A, Takeda A, Hirai K, Zhu X, Atwood CS, Raina AK, Rottkamp CA, Sayre LM, Friedland RP, Perry G. Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochemistry International. 40: 527-31. PMID 11850109 DOI: 10.1016/S0197-0186(01)00123-1  0.647
2002 Aliev G, Smith MA, Seyidov D, Neal ML, Lamb BT, Nunomura A, Gasimov EK, Vinters HV, Perry G, LaManna JC, Friedland RP. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 12: 21-35. PMID 11770899 DOI: 10.1111/J.1750-3639.2002.Tb00419.X  0.645
2002 Mizrahi EH, Fritsch T, Geldmacher DS, Geldmacher S, Soas AH, Friedland RP, Lerner AJ. Medication use in Alzheimer's disease and healthy aging: Results from a research registry Clinical Gerontologist. 24: 75-84. DOI: 10.1300/J018V24N01_06  0.42
2001 Fritsch T, McClendon MJ, Smyth KA, Lerner AJ, Chen CH, Petot GJ, Debanne SM, Soas A, Friedland RP. Effects of educational attainment on the clinical expression of Alzheimer's disease: results from a research registry. American Journal of Alzheimer's Disease and Other Dementias. 16: 369-76. PMID 11765862 DOI: 10.1177/153331750101600606  0.358
2001 Debanne SM, Petot GJ, Li J, Koss E, Lerner AJ, Riedel TM, Rowland DY, Smyth KA, Friedland RP. On the use of surrogate respondents for controls in a case-control study of Alzheimer's disease. Journal of the American Geriatrics Society. 49: 980-4. PMID 11527491 DOI: 10.1046/J.1532-5415.2001.49190.X  0.341
2001 Aliev G, Smith MA, Turmaine M, Neal ML, Zimina TV, Friedland RP, Perry G, LaManna JC, Burnstock G. Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin-1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. Experimental and Molecular Pathology. 71: 40-54. PMID 11502096 DOI: 10.1006/Exmp.2001.2380  0.551
2001 Bowirrat A, Treves TA, Friedland RP, Korczyn AD. Prevalence of Alzheimer's type dementia in an elderly Arab population. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 8: 119-23. PMID 11284991 DOI: 10.1046/J.1468-1331.2001.00183.X  0.312
2001 Friedland RP, Fritsch T, Smyth KA, Koss E, Lerner AJ, Chen CH, Petot GJ, Debanne SM. Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members. Proceedings of the National Academy of Sciences of the United States of America. 98: 3440-5. PMID 11248097 DOI: 10.1073/Pnas.061002998  0.362
2000 Lerner AJ, Elston RC, Chen CH, Friedland RP. Response of the hypothalamic-pituitary-adrenal axis to lumbar puncture induced stress. Journal of Alzheimer's Disease : Jad. 2: 193-8. PMID 12214083 DOI: 10.3233/Jad-2000-23-401  0.309
2000 Nunomura A, Perry G, Pappolla MA, Friedland RP, Hirai K, Chiba S, Smith MA. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. Journal of Neuropathology and Experimental Neurology. 59: 1011-7. PMID 11089579 DOI: 10.1093/Jnen/59.11.1011  0.605
2000 Bowirrat A, Friedland RP, Chapman J, Korczyn AD. The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency. Neurology. 55: 731. PMID 10980749 DOI: 10.1212/Wnl.55.5.731  0.347
2000 Aliev G, Shi J, Perry G, Friedland RP, Lamanna JC. Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet. The Anatomical Record. 260: 16-25. PMID 10967532 DOI: 10.1002/1097-0185(20000901)260:1<16::Aid-Ar20>3.0.Co;2-2  0.61
2000 Shi J, Perry G, Smith MA, Friedland RP. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiology of Aging. 21: 357-61. PMID 10867221 DOI: 10.1016/S0197-4580(00)00119-6  0.736
2000 Friedland RP, Shi J, Lamanna JC, Smith MA, Perry G. Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease. Annals of the New York Academy of Sciences. 903: 123-8. PMID 10818497 DOI: 10.1111/J.1749-6632.2000.Tb06358.X  0.72
2000 Cook TB, Lerner AJ, Mizrahi EH, Siavalas EL, Friedland RP, Koss E. Increased risk for Alzheimer's disease among women whose spouses engaged in lead-related activities Neurobiology of Aging. 21: 246. DOI: 10.1016/S0197-4580(00)83445-4  0.341
2000 Petot GJ, Cook TB, Chen CH, Riedel TM, Debanne SM, Koss E, Lerner AJ, Friedland RP. A high fat diet during adulthood increases risk for Alzheimer's disease for those with the APOE-ϵ4 allele Neurobiology of Aging. 21: 246. DOI: 10.1016/S0197-4580(00)83444-2  0.353
2000 Guo Z, Adrienne Cupples L, Duara R, Friedland RP, Kukull WA, Kurz A, Green RC, Farrer LA. Does hypertension affect the risk and age at onset of Alzheimer disease? Neurobiology of Aging. 21: 244. DOI: 10.1016/S0197-4580(00)83438-7  0.365
2000 Aliev G, Shi J, LaManna JC, Lamb BT, Friedland RP. Atherosclerotic-like changes of the wall of cerebral microvessels in transgenic mice overexpressing amyloid β Neurobiology of Aging. 21: 267. DOI: 10.1016/S0197-4580(00)83155-3  0.541
2000 Aliev G, Shi J, LaManna JC, Friedland RP, Lamb BT. Mitochondrial abnormalities mark vulnerable neurons in APP YAC transgenic mice Neurobiology of Aging. 21: 267. DOI: 10.1016/S0197-4580(00)83153-X  0.514
2000 Mizrahi EH, Fritsch T, Geldmacher DS, Friedland RP, Lerner AJ. Medication utilization in Alzheimer disease and healthy aging: Results in a research registry Neurobiology of Aging. 21: 26. DOI: 10.1016/S0197-4580(00)82796-7  0.345
2000 Friedland RP, Fritsch T, Smyth KA, Koss E, Lerner AJ, Chen CH, Petot GJ, Debanne SM. Intellectual and physical activities are protective against the development of Alzheimer's disease Neurobiology of Aging. 21: 99. DOI: 10.1016/S0197-4580(00)82668-8  0.369
2000 Farrer LA, Baldwin C, Korczyn A, Bowirrat A, Friedland RP. Genetic linkage studies of Alzheimer's disease in Israeli arabs Neurobiology of Aging. 21: 128. DOI: 10.1016/S0197-4580(00)82377-5  0.366
1999 Shi J, Perry G, Aliev G, Smith MA, Ashe KH, Friedland RP. Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model. Neuroreport. 10: 3229-32. PMID 10574565 DOI: 10.1097/00001756-199910190-00019  0.711
1998 Friedland RP, Krasner B. Managing Alzheimer's patients. Science (New York, N.Y.). 282: 2194-5. PMID 9890825 DOI: 10.1126/Science.282.5397.2194C  0.397
1998 Perry G, Smith MA, McCann CE, Siedlak SL, Jones PK, Friedland RP. Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Research. 791: 63-6. PMID 9593825 DOI: 10.1016/S0006-8993(98)00006-7  0.667
1997 Kalaria RN, Ogeng'o JA, Patel NB, Sayi JG, Kitinya JN, Chande HM, Matuja WB, Mtui EP, Kimani JK, Premkumar DR, Koss E, Gatere S, Friedland RP. Evaluation of risk factors for Alzheimer's disease in elderly east Africans. Brain Research Bulletin. 44: 573-7. PMID 9365800 DOI: 10.1016/S0361-9230(97)00310-9  0.447
1997 Cohen DL, Hedera P, Premkumar DR, Friedland RP, Kalaria RN. Amyloid-beta protein angiopathies masquerading as Alzheimer's disease? Annals of the New York Academy of Sciences. 826: 390-5. PMID 9329710 DOI: 10.1111/J.1749-6632.1997.Tb48490.X  0.483
1997 Friedland RP, Kalaria R, Berridge M, Miraldi F, Hedera P, Reno J, Lyle L, Marotta CA. Neuroimaging of vessel amyloid in Alzheimer's disease. Annals of the New York Academy of Sciences. 826: 242-7. PMID 9329695 DOI: 10.1111/J.1749-6632.1997.Tb48475.X  0.403
1997 Hedera P, Friedland RP. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: study of two American families with predominant dementia. Journal of the Neurological Sciences. 146: 27-33. PMID 9077492 DOI: 10.1016/S0022-510X(96)00272-9  0.322
1997 Lundberg C, Johansson K, Ball K, Bjerre B, Blomqvist C, Braekhus A, Brouwer WH, Bylsma FW, Carr DB, Englund L, Friedland RP, Hakamies-Blomqvist L, Klemetz G, O'Neill D, Odenheimer GL, et al. Dementia and driving: an attempt at consensus. Alzheimer Disease and Associated Disorders. 11: 28-37. PMID 9071442 DOI: 10.1097/00002093-199703000-00006  0.321
1997 Lerner AJ, Hedera P, Koss E, Stuckey J, Friedland RP. Delirium in Alzheimer disease. Alzheimer Disease and Associated Disorders. 11: 16-20. PMID 9071440 DOI: 10.1097/00002093-199703000-00004  0.388
1997 Lerner A, Koss E, Debanne S, Rowland D, Smyth K, Friedland R. Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease Lancet. 349: 403-404. PMID 9033479 DOI: 10.1016/S0140-6736(97)80025-6  0.318
1997 Friedland RP. Molecular Mechanisms of Dementia Neurology. 49: 1192-1192. DOI: 10.1212/Wnl.49.4.1192-A  0.365
1997 Debanne SM, Rowland DY, Friedland R, Lerner A. Smoking and Alzheimer's disease The Lancet. 350: 295. DOI: 10.1016/S0140-6736(05)62267-2  0.336
1997 Friedland R, Smyth K, Cole R, Koss E, Cole R, Lerner A, Rowland D, Debanne S. 1-12-22 Persons with Alzheimer's disease (AD) have reduced activities in early life Journal of the Neurological Sciences. 150: S21. DOI: 10.1016/S0022-510X(97)84926-X  0.406
1996 Salomon AR, Marcinowski KJ, Friedland RP, Zagorski MG. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry. 35: 13568-78. PMID 8885836 DOI: 10.1021/Bi9617264  0.311
1996 Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, Pettegrew JW, Pfeiffer E, Raskind MA, Sano M, Tuszynski MH, Woolson RF. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 47: 705-11. PMID 8797468 DOI: 10.1212/Wnl.47.3.705  0.363
1996 Ogeng'o JA, Cohen DL, Sayi JG, Matuja WB, Chande HM, Kitinya JN, Kimani JK, Friedland RP, Mori H, Kalaria RN. Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans. Brain Pathology (Zurich, Switzerland). 6: 101-7. PMID 8737923 DOI: 10.1111/J.1750-3639.1996.Tb00790.X  0.42
1996 Lerner AJ, Friedland RP. The Evolution of Alzheimer's Disease The Gerontologist. 36: 713-714. DOI: 10.1093/Geront/36.5.713  0.41
1996 O'gengo J, Sayi J, Cohen D, Matuja W, Kitinya J, Kimani J, Friedland R, Kalaria R. 493 Brain amyloid 6 protein deposition in non-demented African subjects from east Africa Neurobiology of Aging. 17: S123. DOI: 10.1016/S0197-4580(96)80495-7  0.315
1996 Friedland R, Smyth K, Esteban-Santillan C, Koss E, Cole R, Lemer A, Strauss M, Whitehouse P, Petot G, Rowland D, Debanne S. 490 Premorbid environmental complexity is reduced in patients with Alzheimer's disease (AD) as compared to age and sex matched controls: Results of a Case-Control Study Neurobiology of Aging. 17: S122. DOI: 10.1016/S0197-4580(96)80492-1  0.405
1995 Hedera P, Lerner AJ, Castellani R, Friedland RP. Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 128: 219-24. PMID 7738598 DOI: 10.1016/0022-510X(94)00222-A  0.381
1994 Lerner AJ, Koss E, Patterson MB, Ownby RL, Hedera P, Friedland RP, Whitehouse PJ. Concomitants of visual hallucinations in Alzheimer's disease. Neurology. 44: 523-7. PMID 8145925 DOI: 10.1212/Wnl.44.3_Part_1.523  0.374
1994 Friedland RP, Majocha RE, Reno JM, Lyle LR, Marotta CA. Development of an anti-A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer's disease. Molecular Neurobiology. 9: 107-13. PMID 7888086 DOI: 10.1007/Bf02816109  0.419
1994 Friedland RP. Epidemiology and neurobiology of the multiple determinants of Alzheimer's disease. Neurobiology of Aging. 15: 239-41. PMID 7838300 DOI: 10.1016/0197-4580(94)90121-X  0.41
1994 Friedland RP. Hannah's Heirs: The Quest for the Genetic Origins of Alzheimer's Disease Neurology. 44: 590-590. DOI: 10.1212/Wnl.44.3_Part_1.590  0.356
1994 Friedland RP. Alzheimer's Disease: Advances in Clinical and Basic Research Neurology. 44: 1989-1989. DOI: 10.1212/Wnl.44.10.1989  0.367
1993 Friedland RP. Epidemiology, education, and the ecology of Alzheimer's disease. Neurology. 43: 246-9. PMID 8437687 DOI: 10.1212/Wnl.43.2.246  0.354
1993 Friedland RP, Koss E, Lerner A, Hedera P, Ellis W, Dronkers N, Ober BA, Jagust WJ. Functional imaging, the frontal lobes, and dementia. Dementia (Basel, Switzerland). 4: 192-203. PMID 8401792 DOI: 10.1159/000107323  0.309
1992 Majocha RE, Reno JM, Friedland RP, VanHaight C, Lyle LR, Marotta CA. Development of a monoclonal antibody specific for beta/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 33: 2184-9. PMID 1460513  0.315
1992 Friedland RP. Alzheimer and the Dementias (Eponymists in Medicine) Neurology. 42: 1258-1258. DOI: 10.1212/Wnl.42.6.1258-A  0.399
1991 Ober BA, Jagust WJ, Koss E, Delis DC, Friedland RP. Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 13: 752-72. PMID 1955530 DOI: 10.1080/01688639108401088  0.396
1991 Godec MS, Asher DM, Masters CL, Kozachuk WE, Friedland RP, Gibbs CJ, Gajdusek DC, Rapoport SI, Schapiro MB. Evidence against the transmissibility of Alzheimer's disease. Neurology. 41: 1320. PMID 1866028 DOI: 10.1212/Wnl.41.8.1320  0.402
1990 Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M, Friedland RP, Rapoport SI. Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Archives of Neurology. 47: 753-60. PMID 2357155 DOI: 10.1001/Archneur.1990.00530070043010  0.312
1990 Ship JA, DeCarli C, Friedland RP, Baum BJ. Diminished submandibular salivary flow in dementia of the Alzheimer type. Journal of Gerontology. 45: M61-6. PMID 2313044 DOI: 10.1093/Geronj/45.2.M61  0.363
1990 Friedland RP, May C, Dahlberg J. The viral hypothesis of Alzheimer's disease. Absence of antibodies to lentiviruses. Archives of Neurology. 47: 177-8. PMID 2302089 DOI: 10.1001/Archneur.1990.00530020083019  0.36
1990 Kaye JA, Grady CL, Haxby JV, Moore A, Friedland RP. Plasticity in the aging brain. Reversibility of anatomic, metabolic, and cognitive deficits in normal-pressure hydrocephalus following shunt surgery. Archives of Neurology. 47: 1336-41. PMID 2252451 DOI: 10.1001/Archneur.1990.00530120082014  0.306
1990 Friedland RP, Luxenberg JS, Koss E. A quantitative study of intracranial calcification in dementia of the Alzheimer type. International Psychogeriatrics / Ipa. 2: 36-43. PMID 2101296 DOI: 10.1017/S104161029000028X  0.414
1990 May C, Haber M, Young SH, Tomai TP, Csako G, Friedland RP. Osmoregulation in alzheimer’s disease Dementia and Geriatric Cognitive Disorders. 1: 90-94. DOI: 10.1159/000107125  0.367
1989 Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF. Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology. 39: 1427-34. PMID 2812318 DOI: 10.1212/Wnl.39.11.1427  0.311
1989 Friedland RP. 'Normal'-pressure hydrocephalus and the saga of the treatable dementias. Jama. 262: 2577-81. PMID 2535659 DOI: 10.1001/Jama.1989.03430180119041  0.303
1989 Schapiro MB, Luxenberg JS, Kaye JA, Haxby JV, Friedland RP, Rapoport SI. Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages. Neurology. 39: 1349-53. PMID 2529453 DOI: 10.1212/Wnl.39.10.1349  0.365
1989 Jagust WJ, Martinez Ba, Friedland RP, Budinger TF, Koss E, Ober BA. Cerebral metabolism in Alzheimer's disease Neurology. 39: 309-309. DOI: 10.1212/Wnl.39.2.309-A  0.382
1988 Koss E, Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology. 38: 1228-32. PMID 3399073 DOI: 10.1212/Wnl.38.8.1228  0.33
1988 Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology. 38: 909-12. PMID 3259296 DOI: 10.1212/Wnl.38.6.909  0.333
1988 Friedland RP, Koss E, Kumar A, Gaine S, Metzler D, Haxby JV, Moore A. Motor vehicle crashes in dementia of the Alzheimer type. Annals of Neurology. 24: 782-6. PMID 3207361 DOI: 10.1002/Ana.410240613  0.321
1988 Kumar A, Koss E, Metzler D, Moore A, Friedland RP. Behavioral symptomatology in dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders. 2: 363-5. PMID 3196470 DOI: 10.1097/00002093-198802040-00005  0.343
1988 Friedland RP, Horwitz B, Koss E. Measurement of disease progression in Alzheimer's disease. Neurobiology of Aging. 9: 95-7. PMID 3132624 DOI: 10.1016/S0197-4580(88)80032-0  0.392
1988 Luxenberg JS, Plato CC, Fox KM, Friedland RP, Rapoport SI. Digital and palmar dermatoglyphics in dementia of the Alzheimer type. American Journal of Medical Genetics. 30: 733-40. PMID 2973233 DOI: 10.1002/Ajmg.1320300306  0.328
1988 Friedland RP, Koss E, Haxby JV, Grady CL, Luxenberg J, Schapiro MB, Kaye J. NIH conference. Alzheimer disease: clinical and biological heterogeneity. Annals of Internal Medicine. 109: 298-311. PMID 2969203 DOI: 10.7326/0003-4819-109-4-298  0.411
1988 Rainero I, May C, Kaye JA, Friedland RP, Rapoport SI. CSF alpha-MSH in dementia of the Alzheimer type. Neurology. 38: 1281-4. PMID 2840605 DOI: 10.1212/Wnl.38.8.1281  0.316
1988 Kaye JA, May C, Atack JR, Daly E, Sweeney DL, Beal MF, Kaufman S, Milstien S, Friedland RP, Rapoport SI. Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease. Annals of Neurology. 24: 647-50. PMID 2462403 DOI: 10.1002/Ana.410240509  0.327
1988 Kaye JA, May C, Daly E, Atack JR, Sweeney DJ, Luxenberg JS, Kay AD, Kaufman S, Milstien S, Friedland RP. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features. Neurology. 38: 554-7. PMID 2451190 DOI: 10.1212/Wnl.38.4.554  0.351
1987 Koss E, Friedland RP. Neuropsychological features of early and late-onset Alzheimer's disease. Archives of Neurology. 44: 797-8. PMID 3632391 DOI: 10.1001/Archneur.1987.00520200005005  0.367
1985 Koss E, Friedland RP, Ober BA, Jagust WJ. Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. The American Journal of Psychiatry. 142: 638-40. PMID 3872604 DOI: 10.1176/Ajp.142.5.638  0.349
1985 Friedland RP, Budinger TF, Koss E, Ober BA. Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neuroscience Letters. 53: 235-40. PMID 3872424 DOI: 10.1016/0304-3940(85)90543-9  0.41
1984 Koss E, Ober BA, Delis DC, Friedland RP. The Stroop color-word test: indicator of dementia severity. The International Journal of Neuroscience. 24: 53-61. PMID 6480252 DOI: 10.3109/00207458409079534  0.34
1984 Friedland RP, Prusiner SB, Jagust WJ, Budinger TF, Davis RL. Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. Journal of Computer Assisted Tomography. 8: 978-81. PMID 6381559 DOI: 10.1097/00004728-198410000-00034  0.36
1984 Friedland RP, Budinger TF, Brant-Zawadzki M, Jagust WJ. The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance. Jama. 252: 2750-2. PMID 6333523 DOI: 10.1001/Jama.252.19.2750  0.357
1983 Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, Ober BA, Huesman RH, Derenzo SE. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. Journal of Computer Assisted Tomography. 7: 590-8. PMID 6602819 DOI: 10.1097/00004728-198308000-00003  0.374
Show low-probability matches.